Announcements Trials
Browse Landscape

Phase

Phase NA 86Phase 2 35Phase 3 13Phase 4 8Phase 1 7Phase 2/3 4Phase 1/2 4Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1Breast 1

Conditions

Liver Neoplasms 1Hepatic Metastasis of Colorectal Cancer 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Radiofrequency Ablation × Clear all
NCT04202978 2020-04-16

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Zhongshan Hospital Xiamen University

Phase 1/2 Unknown
23 enrolled
Gastrointestinal

Hepatic Metastasis of Colorectal Cancer

NCT01853618 2019-12-10

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
61 enrolled 18 charts
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00891475 2014-02-13

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Kidney Cancer Research Bureau

Phase 1/2 Completed
114 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡